Nav: Home

Better models needed to predict risk of atrial fibrillation from medical records

October 12, 2016

An ounce of prevention is worth a pound of cure. That's why Dr. Dawood Darbar, chief of cardiology at the University of Illinois Hospital & Health Sciences System, worked with a team of physicians and researchers to answer one important question: Will a widely accepted atrial fibrillation risk prediction algorithm work when applied to the electronic medical record?

Early identification of patients at risk for atrial fibrillation is essential, Darbar said, to reduce the common and severe complications of stroke, heart failure and death from atrial fibrillation, the most common type of irregular heartbeat.

Risk prediction, he said, should leverage the technology routinely used in clinical practice.

"The electronic medical record is increasingly pervasive in clinical practice, and it is a powerful tool in patient care," said Darbar, who is also professor of medicine and pharmacology in the UIC College of Medicine. "To be effective, risk prediction models need to work when applied to EMRs, where they are most likely to be used by physicians to identify subjects at risk for developing a disease."

In a study published in the journal JAMA Cardiology, Darbar and colleagues found that risk prediction models for atrial fibrillation developed by investigators on the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) trial, did not accurately predict incidence of the condition when it was applied to the EMRs of a large group of patients.

The study looked retrospectively at the medical records of patients who as of December 2005 did not have atrial fibrillation but returned for follow-up care at least three times within the next two years. Researchers used the EMR to follow their health for five years (through December 2010) to see how many developed atrial fibrillation.

They found that the CHARGE-AF risk model, when applied to the EMR, underpredicted the incidence of atrial fibrillation among low-risk subjects -- and overpredicted the incidence among high-risk subjects.

"This study illustrates the challenges of applying a predictive model developed in prospective cohort studies to a real-world EMR setting," Darbar said. "Ultimately, as health care advances, so will the role of the EMR. It follows that risk models should be derived from and validated in EMR cohorts, with an ultimate goal of developing individualized preventive strategies."

The study suggests the model's failure to accurately predict atrial fibrillation may be due to the different baseline characteristics of the prospective and EMR cohorts. Darbar and his co-authors also acknowledge some limitations of the study, including inconsistent EMR data-entry procedures, and an "indication bias," wherein individuals who developed atrial fibrillation likely had more clinical encounters than those who did not.

The U.S. Centers for Disease Control and Prevention estimate that up to 6.1 million people in the United States have atrial fibrillation and that the condition contributes to approximately 130,000 deaths each year.
Co-authors on the paper include Dr. Matthew J. Kolek, Amy J. Graves, Meng Xu, Aihua Bian, Pedro Luis Teizeira, Dr. M. Benjamin Shoemaker, Dr. Babar Parvez, Dr. Joshua C. Denny, Frank E. Harrel and Dr. Dan Roden from the Vanderbilt University School of Medicine; Hua Xu of the University of Texas at Houston; Susan R Heckbert of the University of Washington; Dr. Patrick T. Ellinor of Massachusetts General Hospital; Dr. Emelia J. Benjamin of Boston University; Dr. Alvaro Alonso of Emory University; Karel G.M. Moons of University Medical Center Utrecht in the Netherlands; and Ayumi K. Shintani of Osaka University in Japan.

This study was funded by Clinical and Translational Science Award UL1TR000445 from the National Center for Advancing Translational Sciences, the Cohorts for Heart and Aging Research in Genomic Epidemiology Challenge, and grants 1RC1HL101056, 2R01HL092577, 2R01HL092217, and N01HC25195 from the National Heart, Lung, and Blood Institute.

University of Illinois at Chicago

Related Atrial Fibrillation Articles:

Sleep apnea may increase atrial fibrillation risk
Obstructive sleep apnea (OSA) may increase the risk of developing atrial fibrillation (AF), according to new research presented at the ATS 2017 International Conference.
New study identifies biomarker that may indicate risk of atrial fibrillation
Researchers have identified a microRNA biomarker that demonstrates a strong association with the incidence of atrial fibrillation, the most common abnormal heart rhythm.
More women with atrial fibrillation die after ER discharge than men
A new study from the University of Alberta adds to the growing evidence that women with cardiovascular disease may receive different health care from men -- and experience worse outcomes.
Big women have nearly threefold greater risk of atrial fibrillation
Big women have a nearly threefold greater risk of atrial fibrillation than small women, according to research presented today at EuroPrevent 2017.
Most atrial fibrillation patients don't get preventive drug before stroke
More than 80 percent of stroke patients with a history of atrial fibrillation either received not enough or no anticoagulation therapy prior to having a stroke, despite the drugs' proven record of reducing stroke risk, according to a Duke Clinical Research Institute study.
More than half of atrial fibrillation patients become asymptomatic after catheter ablation
More than half of patients with atrial fibrillation become asymptomatic after catheter ablation, reports the largest study of the procedure published today in European Heart Journal.
Medication adherence a problem in atrial fibrillation patients
Anticoagulant therapy is important for stroke prevention in people with atrial fibrillation, but a new study shows many people don't stick with it.
Atrial fibrillation patients are at increased risk of dementia, regardless of anticoagulation use
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.
iPhone camera application may detect atrial fibrillation
A smartphone application made it possible to use the iPhone camera to detect atrial fibrillation via facial signals and without physical contact, according to a preliminary study presented at the American Heart Association's Scientific Sessions 2016.
Study reports progress in preventing bleeding in atrial fibrillation
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care.

Related Atrial Fibrillation Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.